Position in LLY
as of Jun 30, 2026
· filed Aug 11, 2026
Position Value
$11,440,164
+$2,618,650 QoQ
Shares Held
9,538
-0.6% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.32%
of 13F equity value
Holder Rank
#1,185
of 4,601 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in LLY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026PROFUND ADVISORS LLC holds $71,666,047 across 14 Drug Manufacturers - General names. LLY ranks #3 (16.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | AMGN |
Amgen Inc
|
51,320 | $18,583,998 | |
| 2 | GILD |
Gilead Sciences, Inc.
|
110,868 | $14,007,063 | |
| 3 | LLY |
ELI LILLY & Co
This page
|
9,538 | $11,440,164 | |
| 4 | JNJ |
Johnson & Johnson
|
32,688 | $8,301,771 | |
| 5 | ABBV |
AbbVie Inc.
|
26,168 | $6,584,915 | |
| 6 | MRK |
Merck & Co., Inc.
|
33,549 | $4,311,046 | |
| 7 | BIIB |
Biogen Inc.
|
8,560 | $1,849,473 | |
| 8 | PFE |
Pfizer Inc
|
73,381 | $1,767,014 |
All Filings in LLY
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $11,440,164 | 9,538 | Shares | Sole | 2026-08-11 | |
| 2026-03-31 | $8,821,514 | 9,591 | Shares | Sole | 2026-04-27 | |
| 2025-12-31 | $15,142,242 | 14,090 | Shares | Sole | 2026-02-06 | |
| 2025-09-30 | $8,784,419 | 11,513 | Shares | Sole | 2025-11-06 | |
| 2025-06-30 | $9,945,243 | 12,758 | Shares | Sole | 2025-08-07 | |
| 2025-03-31 | $9,691,227 | 11,734 | Shares | Sole | 2025-05-08 | |
| 2024-12-31 | $9,817,524 | 12,717 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $11,072,478 | 12,498 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $12,166,496 | 13,438 | Shares | Sole | 2024-08-13 | |
| 2024-03-31 | $10,707,063 | 13,763 | Shares | Sole | 2024-05-08 | |
| 2023-12-31 | $7,579,708 | 13,003 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $7,180,890 | 13,369 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $6,523,042 | 13,909 | Shares | Sole | 2023-08-10 | |
| 2023-03-31 | $4,843,595 | 14,104 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $7,570,327 | 20,693 | Shares | Sole | 2023-02-02 | |
| 2022-09-30 | $4,811,771 | 14,881 | Shares | Sole | 2022-11-07 | |
| 2022-06-30 | $5,136,127 | 15,841 | Shares | Sole | 2022-08-01 | |
| 2022-03-31 | $5,235,129 | 18,281 | Shares | Sole | 2022-05-10 | |
| 2021-12-31 | $6,046,179 | 21,889 | Shares | Sole | 2022-02-08 | |
| 2021-09-30 | $4,534,818 | 19,627 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $4,554,594 | 19,844 | Shares | Sole | 2021-08-12 | |
| 2021-03-31 | $3,687,639 | 19,739 | Shares | Sole | 2021-05-14 | |
| 2020-12-31 | $3,885,683 | 23,014 | Shares | Sole | 2021-02-09 | |
| 2020-09-30 | $3,376,780 | 22,813 | Shares | Sole | 2020-11-13 | |
| 2020-06-30 | $4,692,592 | 28,582 | Shares | Sole | 2020-08-03 | |
| 2020-03-31 | $3,035,609 | 21,883 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||